Details for: CDC14A

Gene ID: 8556

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: CDC14A

Ensembl ID: ENSG00000079335

Description: cell division cycle 14A

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • podocyte CL0000653
    CSI 18.64
    rCSI 82.81%
    PRS 71.83
  • kidney connecting tubule epithelial cell CL1000768
    CSI 8.75
    rCSI 22.18%
    PRS 61.22
  • mucosal invariant T cell CL0000940
    CSI 7.76
    rCSI 6.27%
    PRS 81.78
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 7.43
    rCSI 8.58%
    PRS 63.86
  • intermediate monocyte CL0002393
    CSI 6.35
    rCSI 9.57%
    PRS 76.76
  • mature T cell CL0002419
    CSI 6.3
    rCSI 4.9%
    PRS 87.51
  • small intestine goblet cell CL1000495
    CSI 6.29
    rCSI 13.78%
    PRS 78.29
  • type B pancreatic cell CL0000169
    CSI 5.82
    rCSI 12.89%
    PRS 70.31
  • Schwann cell CL0002573
    CSI 5.64
    rCSI 16.04%
    PRS 68.28
  • double negative thymocyte CL0002489
    CSI 5.45
    rCSI 3.79%
    PRS 82.97
  • pro-B cell CL0000826
    CSI 5.39
    rCSI 4.47%
    PRS 73.92
  • mesothelial cell CL0000077
    CSI 5.17
    rCSI 20.2%
    PRS 48.66
  • CD4-positive helper T cell CL0000492
    CSI 5.09
    rCSI 3.85%
    PRS 84.7
  • cardiac endothelial cell CL0010008
    CSI 4.85
    rCSI 19.57%
    PRS 70.77
  • L6b glutamatergic cortical neuron CL4023038
    CSI 4.78
    rCSI 14.94%
    PRS 54.53
  • glioblast CL0000030
    CSI 4.64
    rCSI 7.4%
    PRS 63.23
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 4.62
    rCSI 6.34%
    PRS 88.81
  • bronchus fibroblast of lung CL2000093
    CSI 4.48
    rCSI 3.64%
    PRS 71.58
  • radial glial cell CL0000681
    CSI 4.38
    rCSI 6.08%
    PRS 70.03
  • ionocyte CL0005006
    CSI 4.16
    rCSI 4.46%
    PRS 72.08
  • astrocyte of the cerebral cortex CL0002605
    CSI 4.15
    rCSI 9.3%
    PRS 53.33
  • luminal epithelial cell of mammary gland CL0002326
    CSI 4.13
    rCSI 7.5%
    PRS 84.51
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 4.01
    rCSI 3.05%
    PRS 84.21
  • lung secretory cell CL1000272
    CSI 3.95
    rCSI 9.79%
    PRS 70.5
  • naive T cell CL0000898
    CSI 3.73
    rCSI 2.6%
    PRS 85.86
  • innate lymphoid cell CL0001065
    CSI 3.69
    rCSI 7.61%
    PRS 70.77
  • adipocyte CL0000136
    CSI 3.62
    rCSI 4.65%
    PRS 62.62
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 3.62
    rCSI 14.11%
    PRS 89.21
  • cardiac neuron CL0010022
    CSI 3.55
    rCSI 11.35%
    PRS 68.64
  • common myeloid progenitor CL0000049
    CSI 3.5
    rCSI 2.83%
    PRS 73.52
  • blood vessel endothelial cell CL0000071
    CSI 3.42
    rCSI 7.09%
    PRS 68.51
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 3.27
    rCSI 2.3%
    PRS 87.25
  • alveolar adventitial fibroblast CL4028006
    CSI 3.26
    rCSI 5.15%
    PRS 73.49
  • T-helper 17 cell CL0000899
    CSI 3.1
    rCSI 2.46%
    PRS 90.27
  • T follicular helper cell CL0002038
    CSI 3.08
    rCSI 2.3%
    PRS 85.46
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 3
    rCSI 2.15%
    PRS 84.95
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 2.96
    rCSI 7.71%
    PRS 72.09
  • alveolar macrophage CL0000583
    CSI 2.95
    rCSI 4.86%
    PRS 76.67
  • pulmonary capillary endothelial cell CL4028001
    CSI 2.95
    rCSI 5.63%
    PRS 83.67
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 2.94
    rCSI 2.89%
    PRS 86.04
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 2.89
    rCSI 2.68%
    PRS 88.21
  • cerebral cortex endothelial cell CL1001602
    CSI 2.77
    rCSI 4.79%
    PRS 62.06
  • neural crest cell CL0011012
    CSI 2.69
    rCSI 2.12%
    PRS 58.88
  • Kupffer cell CL0000091
    CSI 2.64
    rCSI 6.03%
    PRS 72.24
  • mature astrocyte CL0002627
    CSI 2.58
    rCSI 10.98%
    PRS 63.87
  • precursor B cell CL0000817
    CSI 2.58
    rCSI 2.26%
    PRS 79.93
  • renal interstitial pericyte CL1001318
    CSI 2.57
    rCSI 7.08%
    PRS 66.43
  • alpha-beta T cell CL0000789
    CSI 2.51
    rCSI 2.95%
    PRS 86.35
  • naive B cell CL0000788
    CSI 2.5
    rCSI 2.15%
    PRS 78.99
  • group 3 innate lymphoid cell CL0001071
    CSI 2.44
    rCSI 1.83%
    PRS 77.46
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.43
    rCSI 1.63%
    PRS 84.67
  • multi-ciliated epithelial cell CL0005012
    CSI 2.42
    rCSI 2.41%
    PRS 65.1
  • T-helper 1 cell CL0000545
    CSI 2.42
    rCSI 4.36%
    PRS 89.3
  • retinal rod cell CL0000604
    CSI 2.42
    rCSI 4.26%
    PRS 67.55
  • endothelial cell of placenta CL0009092
    CSI 2.33
    rCSI 11.5%
    PRS 81.44
  • fibroblast of cardiac tissue CL0002548
    CSI 2.33
    rCSI 11.16%
    PRS 71.35
  • hepatic stellate cell CL0000632
    CSI 2.31
    rCSI 8.64%
    PRS 63.47
  • Bergmann glial cell CL0000644
    CSI 2.3
    rCSI 3.15%
    PRS 63.71
  • endocardial cell CL0002350
    CSI 2.21
    rCSI 10.6%
    PRS 69.16
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.2
    rCSI 2.63%
    PRS 88.43
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.18
    rCSI 1.29%
    PRS 87.67
  • mononuclear phagocyte CL0000113
    CSI 2.17
    rCSI 4.79%
    PRS 75.73
  • ependymal cell CL0000065
    CSI 2.14
    rCSI 4.35%
    PRS 49.7
  • Mueller cell CL0000636
    CSI 2.12
    rCSI 4.83%
    PRS 62.87
  • ciliated epithelial cell CL0000067
    CSI 2.11
    rCSI 1.86%
    PRS 59.7
  • vascular leptomeningeal cell CL4023051
    CSI 2.07
    rCSI 3.62%
    PRS 64.08
  • erythroblast CL0000765
    CSI 2.05
    rCSI 5.45%
    PRS 80.25
  • epithelial cell of proximal tubule CL0002306
    CSI 2.04
    rCSI 4.98%
    PRS 64.63
  • conjunctival epithelial cell CL1000432
    CSI 2.03
    rCSI 3.11%
    PRS 72.13
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 2.03
    rCSI 1.57%
    PRS 73.54
  • lung neuroendocrine cell CL1000223
    CSI 2.01
    rCSI 2.97%
    PRS 76.22
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 1.98
    rCSI 2.8%
    PRS 67.71
  • colon epithelial cell CL0011108
    CSI 1.94
    rCSI 2.03%
    PRS 68.54
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 1.9
    rCSI 1.87%
    PRS 88.24
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.83
    rCSI 3.13%
    PRS 86.6
  • chondrocyte CL0000138
    CSI 1.75
    rCSI 2.78%
    PRS 64.18
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 1.74
    rCSI 1.57%
    PRS 68.83
  • choroid plexus epithelial cell CL0000706
    CSI 1.63
    rCSI 2.67%
    PRS 60.49
  • renal beta-intercalated cell CL0002201
    CSI 1.61
    rCSI 3.84%
    PRS 71.83
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 1.61
    rCSI 4.16%
    PRS 66.48
  • BEST4+ enteroycte CL4030026
    CSI 1.59
    rCSI 1.98%
    PRS 73.16
  • ciliated cell CL0000064
    CSI 1.59
    rCSI 2.57%
    PRS 67.18
  • regulatory T cell CL0000815
    CSI 1.56
    rCSI 1.81%
    PRS 77
  • pulmonary artery endothelial cell CL1001568
    CSI 1.55
    rCSI 2.11%
    PRS 81.5
  • pulmonary alveolar type 1 cell CL0002062
    CSI 1.54
    rCSI 8.88%
    PRS 69.11
  • CD14-positive monocyte CL0001054
    CSI 1.53
    rCSI 1.91%
    PRS 81.95
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 1.53
    rCSI 3.95%
    PRS 91.52
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 1.52
    rCSI 1.38%
    PRS 84.9
  • lung ciliated cell CL1000271
    CSI 1.51
    rCSI 1.75%
    PRS 62.66
  • granulocyte CL0000094
    CSI 1.49
    rCSI 2.28%
    PRS 80.27
  • retinal cone cell CL0000573
    CSI 1.47
    rCSI 2.37%
    PRS 60.87
  • retinal blood vessel endothelial cell CL0002585
    CSI 1.44
    rCSI 2.3%
    PRS 75.65
  • renal principal cell CL0005009
    CSI 1.43
    rCSI 3.71%
    PRS 73.71
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 1.4
    rCSI 2.54%
    PRS 62.79
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 1.37
    rCSI 1.86%
    PRS 91.47
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 1.37
    rCSI 3.68%
    PRS 77.76
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 1.35
    rCSI 2.7%
    PRS 85.91
  • myeloid dendritic cell CL0000782
    CSI 1.35
    rCSI 1.96%
    PRS 85.94
  • pulmonary ionocyte CL0017000
    CSI 1.29
    rCSI 1.56%
    PRS 78.54
  • cardiac muscle cell CL0000746
    CSI 1.26
    rCSI 1.8%
    PRS 60.96
  • cytotoxic T cell CL0000910
    CSI 0.2
    rCSI 1.1%
    PRS 78.5%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.4
    rCSI 2.4%
    PRS 92.7%
  • glial cell CL0000125
    CSI 0.5
    rCSI 1.8%
    PRS 62.0%
  • regular atrial cardiac myocyte CL0002129
    CSI 0.6
    rCSI 1.9%
    PRS 69.1%
  • enteroglial cell CL4040002
    CSI 0.7
    rCSI 3.6%
    PRS 74.8%
  • type EC enteroendocrine cell CL0000577
    CSI 0.7
    rCSI 2.4%
    PRS 77.9%
  • blood vessel smooth muscle cell CL0019018
    CSI 0.7
    rCSI 5.7%
    PRS 65.1%
  • stromal cell CL0000499
    CSI 0.7
    rCSI 2.0%
    PRS 67.2%
  • neural progenitor cell CL0011020
    CSI 0.7
    rCSI 3.2%
    PRS 60.6%
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 0.9
    rCSI 1.9%
    PRS 66.5%
  • enterocyte of epithelium of large intestine CL0002071
    CSI 0.9
    rCSI 4.8%
    PRS 79.1%
  • parietal epithelial cell CL1000452
    CSI 1.0
    rCSI 2.6%
    PRS 62.5%
  • basophil CL0000767
    CSI 1.0
    rCSI 2.1%
    PRS 85.7%
  • luminal cell of prostate epithelium CL0002340
    CSI 1.0
    rCSI 5.5%
    PRS 81.2%
  • keratocyte CL0002363
    CSI 1.1
    rCSI 2.6%
    PRS 77.0%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 1.1
    rCSI 3.3%
    PRS 89.4%
  • helper T cell CL0000912
    CSI 1.2
    rCSI 1.6%
    PRS 73.7%
  • Hofbauer cell CL3000001
    CSI 1.2
    rCSI 2.2%
    PRS 81.4%
  • enteroendocrine cell of small intestine CL0009006
    CSI 1.2
    rCSI 2.6%
    PRS 82.1%
  • mesangial cell CL0000650
    CSI 1.2
    rCSI 5.0%
    PRS 82.6%
  • cardiac muscle cell CL0000746
    CSI 1.3
    rCSI 1.8%
    PRS 61.0%
  • pulmonary ionocyte CL0017000
    CSI 1.3
    rCSI 1.6%
    PRS 78.5%
  • myeloid dendritic cell CL0000782
    CSI 1.4
    rCSI 2.0%
    PRS 85.9%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 1.4
    rCSI 2.7%
    PRS 85.9%
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 1.4
    rCSI 3.7%
    PRS 77.8%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 1.4
    rCSI 1.9%
    PRS 91.5%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 1.4
    rCSI 2.5%
    PRS 62.8%
  • renal principal cell CL0005009
    CSI 1.4
    rCSI 3.7%
    PRS 73.7%
  • retinal blood vessel endothelial cell CL0002585
    CSI 1.4
    rCSI 2.3%
    PRS 75.7%
  • retinal cone cell CL0000573
    CSI 1.5
    rCSI 2.4%
    PRS 60.9%
  • granulocyte CL0000094
    CSI 1.5
    rCSI 2.3%
    PRS 80.3%
  • lung ciliated cell CL1000271
    CSI 1.5
    rCSI 1.8%
    PRS 62.7%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 1.5
    rCSI 1.4%
    PRS 84.9%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 1.5
    rCSI 4.0%
    PRS 91.5%
  • CD14-positive monocyte CL0001054
    CSI 1.5
    rCSI 1.9%
    PRS 82.0%
  • pulmonary alveolar type 1 cell CL0002062
    CSI 1.5
    rCSI 8.9%
    PRS 69.1%
  • pulmonary artery endothelial cell CL1001568
    CSI 1.6
    rCSI 2.1%
    PRS 81.5%
  • regulatory T cell CL0000815
    CSI 1.6
    rCSI 1.8%
    PRS 77.0%
  • ciliated cell CL0000064
    CSI 1.6
    rCSI 2.6%
    PRS 67.2%
  • BEST4+ enteroycte CL4030026
    CSI 1.6
    rCSI 2.0%
    PRS 73.2%
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 1.6
    rCSI 4.2%
    PRS 66.5%
  • renal beta-intercalated cell CL0002201
    CSI 1.6
    rCSI 3.8%
    PRS 71.8%
  • choroid plexus epithelial cell CL0000706
    CSI 1.6
    rCSI 2.7%
    PRS 60.5%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 1.7
    rCSI 1.6%
    PRS 68.8%
  • chondrocyte CL0000138
    CSI 1.8
    rCSI 2.8%
    PRS 64.2%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.8
    rCSI 3.1%
    PRS 86.6%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 1.9
    rCSI 1.9%
    PRS 88.2%
  • colon epithelial cell CL0011108
    CSI 1.9
    rCSI 2.0%
    PRS 68.5%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 2.0
    rCSI 2.8%
    PRS 67.7%
  • lung neuroendocrine cell CL1000223
    CSI 2.0
    rCSI 3.0%
    PRS 76.2%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 2.0
    rCSI 1.6%
    PRS 73.5%
  • conjunctival epithelial cell CL1000432
    CSI 2.0
    rCSI 3.1%
    PRS 72.1%
  • epithelial cell of proximal tubule CL0002306
    CSI 2.0
    rCSI 5.0%
    PRS 64.6%
  • erythroblast CL0000765
    CSI 2.1
    rCSI 5.5%
    PRS 80.3%
  • vascular leptomeningeal cell CL4023051
    CSI 2.1
    rCSI 3.6%
    PRS 64.1%
  • ciliated epithelial cell CL0000067
    CSI 2.1
    rCSI 1.9%
    PRS 59.7%
  • Mueller cell CL0000636
    CSI 2.1
    rCSI 4.8%
    PRS 62.9%
  • ependymal cell CL0000065
    CSI 2.1
    rCSI 4.4%
    PRS 49.7%
  • mononuclear phagocyte CL0000113
    CSI 2.2
    rCSI 4.8%
    PRS 75.7%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.2
    rCSI 1.3%
    PRS 87.7%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.2
    rCSI 2.6%
    PRS 88.4%
  • endocardial cell CL0002350
    CSI 2.2
    rCSI 10.6%
    PRS 69.2%
  • Bergmann glial cell CL0000644
    CSI 2.3
    rCSI 3.2%
    PRS 63.7%
  • hepatic stellate cell CL0000632
    CSI 2.3
    rCSI 8.6%
    PRS 63.5%
  • fibroblast of cardiac tissue CL0002548
    CSI 2.3
    rCSI 11.2%
    PRS 71.4%
  • endothelial cell of placenta CL0009092
    CSI 2.3
    rCSI 11.5%
    PRS 81.4%
  • retinal rod cell CL0000604
    CSI 2.4
    rCSI 4.3%
    PRS 67.6%
  • T-helper 1 cell CL0000545
    CSI 2.4
    rCSI 4.4%
    PRS 89.3%
  • multi-ciliated epithelial cell CL0005012
    CSI 2.4
    rCSI 2.4%
    PRS 65.1%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.4
    rCSI 1.6%
    PRS 84.7%
  • group 3 innate lymphoid cell CL0001071
    CSI 2.4
    rCSI 1.8%
    PRS 77.5%
  • naive B cell CL0000788
    CSI 2.5
    rCSI 2.2%
    PRS 79.0%
  • alpha-beta T cell CL0000789
    CSI 2.5
    rCSI 3.0%
    PRS 86.4%
  • renal interstitial pericyte CL1001318
    CSI 2.6
    rCSI 7.1%
    PRS 66.4%
  • precursor B cell CL0000817
    CSI 2.6
    rCSI 2.3%
    PRS 79.9%
  • mature astrocyte CL0002627
    CSI 2.6
    rCSI 11.0%
    PRS 63.9%
  • Kupffer cell CL0000091
    CSI 2.6
    rCSI 6.0%
    PRS 72.2%
  • neural crest cell CL0011012
    CSI 2.7
    rCSI 2.1%
    PRS 58.9%
  • cerebral cortex endothelial cell CL1001602
    CSI 2.8
    rCSI 4.8%
    PRS 62.1%
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 2.9
    rCSI 2.7%
    PRS 88.2%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 2.9
    rCSI 2.9%
    PRS 86.0%
  • pulmonary capillary endothelial cell CL4028001
    CSI 3.0
    rCSI 5.6%
    PRS 83.7%
  • alveolar macrophage CL0000583
    CSI 3.0
    rCSI 4.9%
    PRS 76.7%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 3.0
    rCSI 7.7%
    PRS 72.1%
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 3.0
    rCSI 2.2%
    PRS 85.0%
  • T follicular helper cell CL0002038
    CSI 3.1
    rCSI 2.3%
    PRS 85.5%
  • T-helper 17 cell CL0000899
    CSI 3.1
    rCSI 2.5%
    PRS 90.3%
  • alveolar adventitial fibroblast CL4028006
    CSI 3.3
    rCSI 5.2%
    PRS 73.5%
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 3.3
    rCSI 2.3%
    PRS 87.3%
  • blood vessel endothelial cell CL0000071
    CSI 3.4
    rCSI 7.1%
    PRS 68.5%
  • common myeloid progenitor CL0000049
    CSI 3.5
    rCSI 2.8%
    PRS 73.5%
  • cardiac neuron CL0010022
    CSI 3.6
    rCSI 11.4%
    PRS 68.6%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 3.6
    rCSI 14.1%
    PRS 89.2%
  • adipocyte CL0000136
    CSI 3.6
    rCSI 4.7%
    PRS 62.6%
  • innate lymphoid cell CL0001065
    CSI 3.7
    rCSI 7.6%
    PRS 70.8%
  • naive T cell CL0000898
    CSI 3.7
    rCSI 2.6%
    PRS 85.9%
  • lung secretory cell CL1000272
    CSI 4.0
    rCSI 9.8%
    PRS 70.5%
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 4.0
    rCSI 3.1%
    PRS 84.2%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 4.1
    rCSI 7.5%
    PRS 84.5%
  • astrocyte of the cerebral cortex CL0002605
    CSI 4.2
    rCSI 9.3%
    PRS 53.3%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [CDC14A](/details-gene/8556) encodes a dual-specificity protein phosphatase that is a key regulator of cellular division and cytoskeleton organization. Its primary functions are linked to the control of mitotic exit, cytokinesis, and the assembly of cilia. This is reflected in its localization to the centrosome, mitotic spindle, and ciliary structures. While it is broadly involved in the [Cell cycle](/details-cell/R-HSA-1640170), its expression is particularly significant in specialized, terminally differentiated cells such as [podocytes](/details-cell/CL0000653) in the kidney, suggesting non-mitotic roles in maintaining complex cellular architecture. Clinically, mutations in [CDC14A](/details-gene/8556) are linked to autosomal-recessive deafness and male infertility, underscoring its essential role in the development and function of sensory hair cells and spermatogenesis [Link](https://doi.org/10.1016/j.ajhg.2016.04.015) [Link](https://doi.org/10.1093/hmg/ddx440). ## Cellular Roles and Expression Landscape The expression profile of [CDC14A](/details-gene/8556) reveals a complex role that spans both cell proliferation and the maintenance of highly specialized, differentiated cell types. **Overall**, the gene shows the highest significance in renal [podocytes](/details-cell/CL0000653) (CSI: 18.64) and [kidney connecting tubule epithelial cells](/details-cell/CL1000768) (CSI: 8.75). Given that podocytes are terminally differentiated and do not typically divide, this high expression suggests a crucial, non-canonical function beyond cell cycle control, likely related to cytoskeletal maintenance required for the intricate foot processes of these cells. [CDC14A](/details-gene/8556) also demonstrates notable significance across various immune cell lineages, suggesting a role in immune system dynamics. It is a significant marker in [mucosal invariant T cells](/details-cell/CL0000940), [intermediate monocytes](/details-cell/CL0002393), [mature T cells](/details-cell/CL0002419), [double negative thymocytes](/details-cell/CL0002489), [pro-B cells](/details-cell/CL0000826), and [CD4-positive helper T cells](/details-cell/CL0000492). This pattern is consistent with its established role in regulating cell division, a fundamental process during lymphocyte proliferation and clonal expansion. Furthermore, its expression in progenitor cells like [neuroblasts](/details-cell/CL0000338) and specialized secretory cells such as [small intestine goblet cells](/details-cell/CL1000495) and [type B pancreatic cells](/details-cell/CL0000169) highlights its broad involvement in diverse biological contexts that require precise control over cell division and cytoskeletal organization. ## Pathways and Molecular Function [CDC14A](/details-gene/8556) functions as a protein serine/threonine and tyrosine phosphatase ([GO:0004722](https://www.ebi.ac.uk/QuickGO/term/GO:0004722), [GO:0004725](https://www.ebi.ac.uk/QuickGO/term/GO:0004725)). This enzymatic activity is central to its role in fundamental cellular processes. The primary and most well-characterized function of [CDC14A](/details-gene/8556) is the regulation of the [Cell cycle, mitotic](/details-cell/R-HSA-69278). It is a key component of the mitotic exit network, playing a critical role in the [Regulation of exit from mitosis](/details-cell/GO:0007096). Specifically, it participates in the [Conversion from apc/c:cdc20 to apc/c:cdh1 in late anaphase](/details-cell/R-HSA-176407), a crucial switch that ensures the ordered degradation of cell cycle proteins and completion of cell division [Link](https://doi.org/10.1074/jbc.m108126200). Misexpression of [CDC14A](/details-gene/8556) has been shown to disrupt centrosome separation, chromosome segregation, and cytokinesis [Link](https://doi.org/10.1091/mbc.01-11-0535) [Link](https://doi.org/10.1038/ncb777). A second major function is its involvement in ciliogenesis. Functional annotations link [CDC14A](/details-gene/8556) to [Cilium assembly](/details-cell/GO:0060271), with localization to ciliary structures like the [Kinociliary basal body](/details-cell/GO:1902636), [Kinocilium](/details-cell/GO:0060091), and [Stereocilium tip](/details-cell/GO:0032426). This role is directly responsible for the [Sensory perception of sound](/details-cell/GO:0007605) and is clinically relevant, as mutations lead to profound congenital deafness due to defective hair cell development [Link](https://doi.org/10.1016/j.ajhg.2016.04.015). ## Research Directions The diverse expression pattern and dual functions of [CDC14A](/details-gene/8556) in both cell cycle control and differentiated cell maintenance present several avenues for future research. **Proposed Hypotheses:** 1. **Non-mitotic cytoskeletal regulation in podocytes:** The exceptionally high expression of [CDC14A](/details-gene/8556) in terminally differentiated [podocytes](/details-cell/CL0000653) suggests it plays a critical, non-mitotic role. We hypothesize that [CDC14A](/details-gene/8556) is a key phosphatase that maintains the stability of the podocyte actin cytoskeleton and filtration slit diaphragm by dephosphorylating specific structural or regulatory proteins, thereby preventing podocyte effacement and aberrant cell cycle re-entry seen in chronic kidney disease. 2. **Regulation of T cell quiescence:** The expression of [CDC14A](/details-gene/8556) in various T cell subsets suggests a role in lymphocyte population dynamics. We hypothesize that [CDC14A](/details-gene/8556) is essential for the transition from a rapidly proliferating effector [T cell](/details-cell/CL0000084) to a long-lived, quiescent memory [T cell](/details-cell/CL0000084) by facilitating a stable exit from the cell cycle following an immune response. 3. **Role in male fertility:** Based on clinical findings of infertility [Link](https://doi.org/10.1093/hmg/ddx440), we hypothesize that [CDC14A](/details-gene/8556) is required for proper chromosome segregation and cytokinesis during meiosis in spermatocytes, and its absence leads to aneuploidy and failed spermatid development. **Key Experimental Approach:** To test the hypothesis regarding the role of [CDC14A](/details-gene/8556) in [podocytes](/details-cell/CL0000653), a podocyte-specific conditional knockout mouse model (e.g., *Nphs2-Cre; Cdc14afl/fl*) should be generated. These mice could be subjected to a model of kidney injury (e.g., adriamycin nephropathy). The primary readouts would include measurements of albuminuria, histological analysis of glomeruli, and ultra-structural examination of podocyte foot processes via electron microscopy. Additionally, phosphoproteomic analysis of isolated podocytes from knockout versus control mice would identify direct substrates of CDC14A and reveal the specific signaling pathways it regulates to maintain podocyte architecture. **Therapeutic Potential:** As a crucial cell cycle regulator, [CDC14A](/details-gene/8556) presents a complex therapeutic profile. Its characterization as a putative tumor suppressor suggests that its loss could contribute to tumorigenesis, making it a candidate for gene restoration or pathway activation therapies in specific cancers [Link](https://doi.org/10.1074/jbc.272.47.29403). However, its essential, non-redundant roles in hearing and fertility indicate that systemic inhibition of [CDC14A](/details-gene/8556) would likely cause severe on-target toxicities. Therefore, therapeutic strategies would need to be highly targeted, perhaps focusing on modulating its activity or downstream effectors rather than complete inhibition, and would be most applicable in diseases where its function is aberrantly lost.

Genular Protein ID: 612316906

Symbol: CC14A_HUMAN

Name: Dual specificity protein phosphatase CDC14A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 9367992

Title: A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast.

PubMed ID: 9367992

DOI: 10.1074/jbc.272.47.29403

PubMed ID: 10409437

Title: Genomic structure, chromosomal location, and mutation analysis of the human CDC14A gene.

PubMed ID: 10409437

DOI: 10.1006/geno.1999.5863

PubMed ID: 16710414

Title: The DNA sequence and biological annotation of human chromosome 1.

PubMed ID: 16710414

DOI: 10.1038/nature04727

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11598127

Title: Regulation of the anaphase-promoting complex by the dual specificity phosphatase human Cdc14a.

PubMed ID: 11598127

DOI: 10.1074/jbc.m108126200

PubMed ID: 12134069

Title: Disruption of centrosome structure, chromosome segregation, and cytokinesis by misexpression of human Cdc14A phosphatase.

PubMed ID: 12134069

DOI: 10.1091/mbc.01-11-0535

PubMed ID: 11901424

Title: Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation.

PubMed ID: 11901424

DOI: 10.1038/ncb777

PubMed ID: 15263015

Title: Relocation of Aurora B from centromeres to the central spindle at the metaphase to anaphase transition requires MKlp2.

PubMed ID: 15263015

DOI: 10.1083/jcb.200403084

PubMed ID: 17488717

Title: Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation.

PubMed ID: 17488717

DOI: 10.1074/jbc.m702990200

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 27259055

Title: Mutations in CDC14A, encoding a protein phosphatase involved in hair cell ciliogenesis, cause autosomal-recessive severe to profound deafness.

PubMed ID: 27259055

DOI: 10.1016/j.ajhg.2016.04.015

PubMed ID: 29293958

Title: CDC14A phosphatase is essential for hearing and male fertility in mouse and human.

PubMed ID: 29293958

DOI: 10.1093/hmg/ddx440

PubMed ID: 16959974

Title: The consensus coding sequences of human breast and colorectal cancers.

PubMed ID: 16959974

DOI: 10.1126/science.1133427

Sequence Information:

  • Length: 594
  • Mass: 66574
  • Checksum: D5552E2BAEEA84DF
  • Sequence:
  • MAAESGELIG ACEFMKDRLY FATLRNRPKS TVNTHYFSID EELVYENFYA DFGPLNLAMV 
    YRYCCKLNKK LKSYSLSRKK IVHYTCFDQR KRANAAFLIG AYAVIYLKKT PEEAYRALLS 
    GSNPPYLPFR DASFGNCTYN LTILDCLQGI RKGLQHGFFD FETFDVDEYE HYERVENGDF 
    NWIVPGKFLA FSGPHPKSKI ENGYPLHAPE AYFPYFKKHN VTAVVRLNKK IYEAKRFTDA 
    GFEHYDLFFI DGSTPSDNIV RRFLNICENT EGAIAVHCKA GLGRTGTLIA CYVMKHYRFT 
    HAEIIAWIRI CRPGSIIGPQ QHFLEEKQAS LWVQGDIFRS KLKNRPSSEG SINKILSGLD 
    DMSIGGNLSK TQNMERFGED NLEDDDVEMK NGITQGDKLR ALKSQRQPRT SPSCAFRSDD 
    TKGHPRAVSQ PFRLSSSLQG SAVTLKTSKM ALSPSATAKR INRTSLSSGA TVRSFSINSR 
    LASSLGNLNA ATDDPENKKT SSSSKAGFTA SPFTNLLNGS SQPTTRNYPE LNNNQYNRSS 
    NSNGGNLNSP PGPHSAKTEE HTTILRPSYT GLSSSSARFL SRSIPSLQSE YVHY

Genular Protein ID: 2846841378

Symbol: B4DY86_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 565
  • Mass: 62816
  • Checksum: E914AB0B84A6C7C2
  • Sequence:
  • MVYRYCCKLN KKLKSYSLSR KKIVHYTCFD QRKRANAAFL IGAYAVIYLK KTPEEAYRAL 
    LSGSNPPYLP FRDASFGNCT YNLTILDCLQ GIRKGLQHGF FDFETFDVDE YEHYERVENG 
    DFNWIVPGKF LAFSGPHPKS KIENGYPLHA PEAYFPYFKK HNVTAVVRLN KKIYEAKRFT 
    DAGFEHYDLF FIDGSTPSDN IVRRFLNICE NTEGAIAVHC KAGLGRTGTL IACYVMKHYR 
    FTHAEIIAWI RICRPGSIIG PQQHFLEEKQ ASLWVQGDIF RSKLKNRPSN EGGINKILSG 
    LDDMSIGGNL SKTQNMGRFG EDNLEDDDVE MKNGITQGDK LRALKSQRQP RTSPSCAFRS 
    DDTKGHPRAV SQPFRLSSSL QGSAVTLKTS KMALSPSATA KRINRTSLSS GATVRSFSIN 
    SRLASSLGNL NAATDDPENK KTSSSSKAGF TASPFTNLLN GSSQPTTRNY PELNNNQYNR 
    SSNSNGGNLN SPPGPHSAKT EEHTTILRPS YTGLSSSSAR FLSRSIPVSA QTPPPGPQNP 
    ECNFCALPSQ PRLPPKKFNS AKEAF

Genular Protein ID: 2064504910

Symbol: Q59EF4_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 530
  • Mass: 58905
  • Checksum: F54BF28550AAF8B3
  • Sequence:
  • CQLCKKAGSS SLSRKKIVHY TCFDQRKRAN AAFLIGAYAV IYLKKTPEEA YRALLSGSNP 
    PYLPFRDASF GNCTYNLTIL DCLQGIRKGL QHGFFDFETF DVDEYEHYER VENGDFNWIV 
    PGKFLAFSGP HPKSKIENGY PLHAPEAYFP YFKKHNVTAV VRLNKKIYEA KRFTDAGFEH 
    YDLFFIDGST PSDNIVRRFL NICENTEGAI AVHCKAGLGR TGTLIACYVM KHYRFTHAEI 
    IAWIRICRPG SIIGPQQHFL EEKQASLWVQ GDIFRSKLKN RPSSEGSINK ILSGLDDMSI 
    GGNLSKTQNM ERFGEDNLED DDVEMKNGIT QGDKLRALKS QRQPRTSPSC AFRSDDTKGH 
    PRAVSQPFRL SSSLQGSAVT LKTSKMALSP SATAKRINRT SLSSGATVRS FSINSRLASS 
    LGNLNAATDD PENKKTSSSS KAGFTASPFT NLLNGSSQPT TRNYPELNNN QYNRSSNSNG 
    GNLNSPPGPH SAKTEEHTTI LRPSYTGLSS SSARFLSRSI PSLQSEYVHY

Genular Protein ID: 205191801

Symbol: A0A0U1RQX7_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 16710414

Title: The DNA sequence and biological annotation of human chromosome 1.

PubMed ID: 16710414

DOI: 10.1038/nature04727

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

Sequence Information:

  • Length: 565
  • Mass: 62891
  • Checksum: E09A5ACEBE63A3CB
  • Sequence:
  • MVYRYCCKLN KKLKSYSLSR KKIVHYTCFD QRKRANAAFL IGAYAVIYLK KTPEEAYRAL 
    LSGSNPPYLP FRDASFGNCT YNLTILDCLQ GIRKGLQHGF FDFETFDVDE YEHYERVENG 
    DFNWIVPGKF LAFSGPHPKS KIENGYPLHA PEAYFPYFKK HNVTAVVRLN KKIYEAKRFT 
    DAGFEHYDLF FIDGSTPSDN IVRRFLNICE NTEGAIAVHC KAGLGRTGTL IACYVMKHYR 
    FTHAEIIAWI RICRPGSIIG PQQHFLEEKQ ASLWVQGDIF RSKLKNRPSS EGSINKILSG 
    LDDMSIGGNL SKTQNMERFG EDNLEDDDVE MKNGITQGDK LRALKSQRQP RTSPSCAFRS 
    DDTKGHPRAV SQPFRLSSSL QGSAVTLKTS KMALSPSATA KRINRTSLSS GATVRSFSIN 
    SRLASSLGNL NAATDDPENK KTSSSSKAGF TASPFTNLLN GSSQPTTRNY PELNNNQYNR 
    SSNSNGGNLN SPPGPHSAKT EEHTTILRPS YTGLSSSSAR FLSRSIPVSA QTPPPGPQNP 
    ECNFCALPSQ PRLPPKKFNS AKEAF